×
-0.000253267146185854 0.000455880863134308 0.00131749569445849 0.00202613716948626 0.00370479181440573 0.00329247290041524 0.00329247290041524 0.00329247290041524
Stockreport

UPDATE 4-U.S. top court rejects Amgen over cholesterol medication patent fight [Reuters]

Amgen, Inc (AMGN)  More Company Research Source: Reuters
Last amgen, inc earnings: 1/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF U.S. top court rejects Amgen over cholesterol medication patent fight WASHINGTON (Reuters) - Amgen Inc on Monday lost its bid at the U.S. Supreme Court to overturn a ruling that kept the Regeneron Pharmaceuticals Inc and Sanofi SA cholesterol-lowering drug Praluent on the market, but the patent dispute among the rival drugmakers will continue in another trial. The justices declined to hear Amgen’s appeal seeking reinstatement of a jury verdict it won against Regeneron and Sanofi in the dispute in which Amgen accused its rivals of infringing its patents relating to its competing drug Repatha and sought to block sales of Praluent. Amgen had asked the justices to overturn a 2017 decision by the U.S. Court of Appeals for the Federal Circuit that set aside the jury’s verdict, nullified a ban imposed by a judge on Praluent sales and ordered a new trial. The sales ban was put on hold while the matter was on appeal, never taking effect. Sanofi and Regeneron said in a joint statement they were [Read more]

IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
Opt-in for
AMGN alerts

from News Quantified
Opt-in for
AMGN alerts

from News Quantified